Concepedia

William Farnaby

WF

15

Publications

1.6K

Citations

13

H-Index

2017

Active since

Affiliations

University of Dundee(Current)

Boehringer Ingelheim (Austria)

Takeda (Japan)

Takeda (United Kingdom)

Boehringer Ingelheim (Germany)

William Farnaby is an author at University of Dundee specializing in medicine, drug discovery, and systems biology.

ORCID

Top concepts

Publications per year

2017–2024

15

Publications

15

BAF complex vulnerabilities in cancer demonstrated via structure-based PROTAC design

William Farnaby, Manfred Koegl, Michael J. Roy et al. · Nature Chemical Biology · 2019 · 553 citations · Full text

, , +10

SPR-Measured Dissociation Kinetics of PROTAC Ternary Complexes Influence Target Degradation Rate

Michael J. Roy, Sandra Winkler, Scott J. Hughes et al. · ACS Chemical Biology · 2019 · 358 citations · Full text

A selective and orally bioavailable VHL-recruiting PROTAC achieves SMARCA2 degradation in vivo

Christiane Kofink, Nicole Trainor, Barbara Mair et al. · Nature Communications · 2022 · 194 citations · Full text

Targeting cancer with small-molecule pan-KRAS degraders

Johannes Popow, William Farnaby, Andreas Gollner et al. · Science · 2024 · 130 citations · Full text

, , +15

Soticlestat, a novel cholesterol 24-hydroxylase inhibitor shows a therapeutic potential for neural hyperexcitation in mice

Toshiya Nishi, Shinichi Kondo, Maki Miyamoto et al. · Scientific Reports · 2020 · 75 citations · Full text

Rows per page

1–5 of 15